Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Himly

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|July 2, 2021
Iron Oxide Nanoparticles in Bioimaging - An Immune PerspectiveMark Geppert, Martin Himly
Frontiers in Pharmacology|July 6, 2016
Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and LimitationsMarkus Steiner, Andrea Harrer, Martin Himly
Vaccines|May 24, 2020
Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under ResearchLitty Johnson, Albert Duschl, Martin Himly
Biomed Research International|January 13, 2017
The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune FunctionsMarkus Steiner, Sara Huber, Andrea Harrer, et al.
Biomedicines|October 23, 2021
Children's Privilege in COVID-19: The Protective Role of the Juvenile Lung Morphometry and Ventilatory Pattern on Airborne SARS-CoV-2 Transmission to Respiratory Epithelial Barriers and Disease SeverityNorbert Hofstätter, Sabine Hofer, Albert Duschl, et al.
Journal of Personalized Medicine|June 2, 2021
SARS-CoV-2-Laden Respiratory Aerosol Deposition in the Lung Alveolar-Interstitial Region Is a Potential Risk Factor for Severe Disease: A Modeling StudySabine Hofer, Norbert Hofstätter, Albert Duschl, et al.
Frontiers in Immunology|May 11, 2017
Nanomaterials in the Context of Type 2 Immune Responses-Fears and PotentialsMartin Himly, Robert Mills-Goodlet, Mark Geppert, et al.
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Development of recombinant allergens for diagnosis and therapyMatthias Egger, Michael Hauser, Martin Himly, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|November 23, 2022
Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populationsSabine Hofer, Norbert Hofstätter, Benjamin Punz, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|August 31, 2010
Characterization of allergoidsMartin Himly, Jerónimo Carnés, Enrique Fernández-Caldas, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|July 2, 2021
Iron Oxide Nanoparticles in Bioimaging - An Immune PerspectiveMark Geppert, Martin Himly
Frontiers in Pharmacology|July 6, 2016
Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and LimitationsMarkus Steiner, Andrea Harrer, Martin Himly
Vaccines|May 24, 2020
Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under ResearchLitty Johnson, Albert Duschl, Martin Himly
Biomed Research International|January 13, 2017
The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune FunctionsMarkus Steiner, Sara Huber, Andrea Harrer, et al.
Biomedicines|October 23, 2021
Children's Privilege in COVID-19: The Protective Role of the Juvenile Lung Morphometry and Ventilatory Pattern on Airborne SARS-CoV-2 Transmission to Respiratory Epithelial Barriers and Disease SeverityNorbert Hofstätter, Sabine Hofer, Albert Duschl, et al.
Journal of Personalized Medicine|June 2, 2021
SARS-CoV-2-Laden Respiratory Aerosol Deposition in the Lung Alveolar-Interstitial Region Is a Potential Risk Factor for Severe Disease: A Modeling StudySabine Hofer, Norbert Hofstätter, Albert Duschl, et al.
Frontiers in Immunology|May 11, 2017
Nanomaterials in the Context of Type 2 Immune Responses-Fears and PotentialsMartin Himly, Robert Mills-Goodlet, Mark Geppert, et al.
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Development of recombinant allergens for diagnosis and therapyMatthias Egger, Michael Hauser, Martin Himly, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|November 23, 2022
Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populationsSabine Hofer, Norbert Hofstätter, Benjamin Punz, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|August 31, 2010
Characterization of allergoidsMartin Himly, Jerónimo Carnés, Enrique Fernández-Caldas, et al.
Pageof 9